Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-20T00:38:35.154Z Has data issue: false hasContentIssue false
  • English
  • Français

Authors' reply

Published online by Cambridge University Press:  02 January 2018

Magali Haas ,
Marielle Eerdekens ,
Pharmaceutica NV ,
Stuart Kushner ,
Julia Singer ,
Ilse Augustyns ,
Pharmaceutica NV ,
Vivek Kusumakar ,
Jorge Quiroz  and
Gahan Pandina
Magali Haas
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium. Email: mhaas8@its.jnj.com
Marielle Eerdekens
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen
Pharmaceutica NV
Affiliation:
Beerse, Belgium
Stuart Kushner
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, LLC, New Jersey, USA
Julia Singer
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen
Ilse Augustyns
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen
Pharmaceutica NV
Affiliation:
(deceased)
Vivek Kusumakar
Affiliation:
(deceased)
Jorge Quiroz
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, LLC, New Jersey, USA
Gahan Pandina
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, LLC, New Jersey, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 194 , Issue 6 , June 2009 , pp. 569
Copyright
Copyright © Royal College of Psychiatrists, 2009 

References

1 Aman, MG, De Smedt, G, Derivan, A, Findling, RL, Group RDBS. Double-blind, placebo-controlled study of risperidone in the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 2002; 159: 1337–46.CrossRefGoogle Scholar
2 Reyes, M, Buitelaar, J, Toren, P, Augustyns, I, Eerdekens, M. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders. Am J Psychiatry 2006; 163: 402–10.CrossRefGoogle ScholarPubMed
3 Stroup, TS, Alves, WM, Hamer, RM, Lieberman, JA. Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations. Nature Rev 2006; 5: 133–46.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.